Heterogeneity of the Filamentous Haemagglutinin of Bordetella pertussis Studied with Monoclonal Antibodies

References

1. Arai H., Munoz J.J. 1979; Purification and crystallisation of fimbrial haemagglutinin from Bordetella pertussis. Infection and Immunity 25:460–462
   [Google Scholar]
2. Arm H., Sato Y. 1976; Separation and characterisation of two distinct haemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochimica et biophysica acta 444:765–782
   [Google Scholar]
3. Ashworth L.A.E., Fitzgeorge R.B., Irons L.I., Morgan C.P., Robinson A. 1982; Rabbit nasopharyngeal colonisation by Bordetella pertussis:the effects of immunisation on clearance and on serum and nasal antibody levels. Journal of Hygiene 88:475–486
   [Google Scholar]
4. Askelof P., GranströM M., Gillenius P., Lindberg A.A. 1982; Purification and characterisation of a fimbrial haemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay. Journal of Medical Microbiology 15:73–413
   [Google Scholar]
5. Cowell J.L., Sato Y., Sato H., An DER LAN B., Manclark C.R. 1981; Separation, purification and properties of the filamentous haemagglutinin and the leukocytosis promoting factor-haemagglu- tinin from Bordetella pertussis. In Seminars in Infectious Diseases IV: Bacterial Vaccines, pp. 371–379 Robbins J.B., Hill J.C. Edited by New York: Thiene-Stratton;
   [Google Scholar]
6. Irons L.I., Maclennan A.P. 1979; Substrate specificity and the purification by affinity combination methods of the two Bordetella pertussishaemagglutinins. In International Symposium on Pertussis pp. 338–349 Manclark C.R., Hill J.C. Edited by Washington, D.C.: U.S. Department of Health, Education and Welfare;
   [Google Scholar]
7. Littlefield J.W. 1964; Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science 145:709–710
   [Google Scholar]
8. Maclennan A.P. 1960; Specific lipopolysaccharides of Bordetella. Biochemical Journal 74:398–409
   [Google Scholar]
9. Mattice W.L., Riser J.M., Clark D.S. 1976; Conformational properties of the complexes formed by proteins and sodium dodecyl sulphate. Biochemistry 15:4264–4272
   [Google Scholar]
10. Munoz J.J., Arai H., Cole R.L. 1981; Mouse- protecting and histamine-sensitising activities of pertussigen and fimbrial haemagglutinin from Bor- detella pertussis. Infection and Immunity 32:243–250
    [Google Scholar]
11. Nakane P.K., Kawaoi A. 1974; Peroxidase- labelled antibody. A new method of conjugation. Journal of Histochemistry and Cytochemistry 22:1084–1091
    [Google Scholar]
12. Nakase Y., Doi M., Kasuga T. 1975; Haemag- glutinating substance of Bordetella pertussis. Japanese Journal of Medical Science and Biology 28:57–59
    [Google Scholar]
13. Parton R., Wardlaw A.C. 1975; Cell envelope proteins of Bordetella pertussis. Journal of Medical Microbiology 8:47–57
    [Google Scholar]
14. Reynolds J.A., Tanford C. 1970; The gross conformation of protein-sodium dodecyl sulphate complexes. Journal of Biological Chemistry 245:5161–5165
    [Google Scholar]
15. Robinson A., Hawkins D.C., Irons L.I. 1981; The preparation of distinct protective antigens from Bordetella pertussis. FEMS Microbiology Letters 10:241–244
    [Google Scholar]
16. Sato Y., Arai H., Suzuki K. 1974; Leukocytosis promoting factor of Bordetella pertussis III. Its identity with protective antigen. Infection and Immunity 9:801–810
    [Google Scholar]
17. Sato Y., Sato H., Izumiya K., Cowell J.L., Manclark C.R. 1981; Role of antibody to filamentous haemagglutinin and to leukocytosis promoting factor-haemagglutinin in immunity to Pertussis. In Seminars in Infectious Diseases IV Bacterial Vaccines pp. 380–385 Robbins J.B., Hill J. C. Edited by New York: Thiene-Stratton;
    [Google Scholar]
18. Towbin H., Staehelin T., Gordon J. 1979; Electophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 76:4350–4354
    [Google Scholar]